甘麦大枣汤抗焦虑作用及机制研究
摘要
目的:甘麦大枣汤抗焦虑作用及作用机制的相关研究。
方法:以小鼠为研究对象,应用高架十字迷宫复制焦虑动物模型,从行为学角度观察性别、体重、测试时间等因素对小鼠高架十字迷宫实验结果的影响;在此基础上进行甘麦大枣汤抗焦虑作用的量效关系和时效关系研究;最后应用高效液相-电化学检测法,测定小鼠海马中5-HT的含量变化,确定甘麦大枣汤抗焦虑作用的作用机制。
结果:
1.性别对高架十字迷宫实验结果的影响:雌性组与雄性组比较OE%、OT%、总次数不具有显著性统计学差异( P>0.05)。
2.体重对高架十字迷宫实验结果的影响:与体重20.0g±1.0g组比较,15.0g±1.0g组OE%具有显著性差异( P<0.05)25.0g±1.0g组OE%具有极显著性差异(P<0.01);15.0g±1.0g组与25.0g±1.0g组OT%均具有极显著性差异(P<0.01);15.0g±1.0g组总次数具有显著性差异(P<0.05)。
3.测试时间对高架十字迷宫实验结果的影响:与测试时间14:00-17:00组比较,19:00-21:00组OE%具有极显著性差异(P<0.01);9:00-12:00组OT%具有显著性差异( P<0.05) 19:00-21:00组OT%具有极显著性差异(P<0.01);9:00-12:00组总次数具有极显著性差异(P<0.01)。
4.从甘麦大枣汤抗焦虑作用的量效关系研究可知:当给药剂量为10倍时OE%与空白组比较具有极显著性差异(P<0.01),给药剂量为20倍时OE%达到最大值与空白组比较具有极显著性差异( P<0.01),继续增加给药剂量药效逐渐降低;当给药剂量为5倍时OT%与空白组比较具有显著性差异(P<0.05),20倍时OT%达到最大值与空白组比较具有极显著性差异(P<0.01),继续增加给药剂量药效逐渐降低。
5.从甘麦大枣汤抗焦虑作用的时效关系研究可知:给药3天时与本组空白组比较,OE%具有显著性差异(P<0.05),给药7天OE%达到最大值与本组空白组比较具有极显著性差异(P<0.01),继续增加给药天数药效逐渐降低;给药5天时与本组空白组比较OT%具有显著性差异(P<0.05),给药7天OT%达到最大值与本组空白组比较具有极显著性差异(P<0.01),继续增加给药天数药效逐渐降低。
6.从甘麦大枣汤抗焦虑作用的作用机制研究可知:甘麦大枣汤能降低小鼠海马内5-HT的含量,与空白组比较具有极显著性差异(P<0.01)。
结论:
1.性别对高架十字迷宫实验结果的影响没有显著性统计学差异。
2.体重对高架十字迷宫实验结果有一定影响,体重为20.0g±1.0g的小鼠焦虑状态最明显。
3.测试时间对高架十字迷宫实验结果有一定影响,测试时间为14:00-17:00时小鼠焦虑状态最明显。
4.甘麦大枣汤抗焦虑作用呈现一定的量效关系和时效关系变化,但是不呈现剂量依赖性。最佳给药剂量为20倍剂量;最佳给药时长为连续给药7天。
5.甘麦大枣汤可能是通过降低小鼠脑内海马区5-HT的含量发挥抗焦虑作用。
Objective: Studies on the anxiolytic effect and function mechanism of Ganmaidazao Tang.
Methods: Take the mice as the object of study, application EPM duplication anxious animal model, from behavior study angle the anti-anxious function. From behavior study angle factors and so on observation sex, weighe, testing time to EPM experiment result influence; Based on this research about dose-response relationship and time-concentration of the Ganmaidazao tang anti-anxious; Used HPLC-EC technique, in determination the region of hippcampus mice 5-HT content change, determined Ganmaidazao Tang affects anxious function mechanism.
Results:
1. Sex to experimental result influence:female group and male group OE%,OT% and locomotor activity P>0.05.
2. Weight to experimental result influence: compares with the weight for 20.0±1.0g group, the weight for 15.0g±1.0g group OE% P<0.05, 25.0g±1.0g group OE%P<0.01;15.0g±1.0g and 25.0g±1.0g group OT%P<0.01; 15.0g±1.0g group locomotor activity P<0.05.
3. Test time to experimental result influence:compares with the 14:00-17:00 group, 19:00-21:00 group OE% P<0.05; 9:00-12:00 group OT% P<0.05, 19:00-21:00 group OT% P<0.01; 9:00-12:00 group locomotor activity P<0.01.
4. The experimental results of the dose-response relationship showed that from the doses of 7.0g/kg started work there was significant difference OE% P<0.01; the doses of 14.g/kg reached the climax, there was extremely significant difference between the OE% and OT%; the doses of 3.5g/kg OT% P<0.05.
5 . The experimental results of the time-response relationship showed: the experimental results of the time- concentration relationship showed that giving medicine for three days started work, OE% P<0.05; giving medicine for seven days reach the climax, there was extremely significant different between OE% and OT% P<0.01; giving medicine for five days OT% P<0.05.
6. The experimental results of function mechanism of Ganmaidazao Tang, it can reduce content 5-HT of the region of hippocampus mice P<0.01.
Conclusion:
1. The sex hasn’t affect EPM results.
2. The weight affects EPM results: weight of 19.0g-21.0g is better.
3. Test time affects EPM results: test time of 14:00-17:00 is better.
4. Ganmaidazao Tang could improve the OE% and OT%,14.0g/kg is choosed for the best doses, seven days is choosed for the best time.
5. Ganmaidazao Tang can reduce content 5-HT of the region of hippcampus mice
方法:以小鼠为研究对象,应用高架十字迷宫复制焦虑动物模型,从行为学角度观察性别、体重、测试时间等因素对小鼠高架十字迷宫实验结果的影响;在此基础上进行甘麦大枣汤抗焦虑作用的量效关系和时效关系研究;最后应用高效液相-电化学检测法,测定小鼠海马中5-HT的含量变化,确定甘麦大枣汤抗焦虑作用的作用机制。
结果:
1.性别对高架十字迷宫实验结果的影响:雌性组与雄性组比较OE%、OT%、总次数不具有显著性统计学差异( P>0.05)。
2.体重对高架十字迷宫实验结果的影响:与体重20.0g±1.0g组比较,15.0g±1.0g组OE%具有显著性差异( P<0.05)25.0g±1.0g组OE%具有极显著性差异(P<0.01);15.0g±1.0g组与25.0g±1.0g组OT%均具有极显著性差异(P<0.01);15.0g±1.0g组总次数具有显著性差异(P<0.05)。
3.测试时间对高架十字迷宫实验结果的影响:与测试时间14:00-17:00组比较,19:00-21:00组OE%具有极显著性差异(P<0.01);9:00-12:00组OT%具有显著性差异( P<0.05) 19:00-21:00组OT%具有极显著性差异(P<0.01);9:00-12:00组总次数具有极显著性差异(P<0.01)。
4.从甘麦大枣汤抗焦虑作用的量效关系研究可知:当给药剂量为10倍时OE%与空白组比较具有极显著性差异(P<0.01),给药剂量为20倍时OE%达到最大值与空白组比较具有极显著性差异( P<0.01),继续增加给药剂量药效逐渐降低;当给药剂量为5倍时OT%与空白组比较具有显著性差异(P<0.05),20倍时OT%达到最大值与空白组比较具有极显著性差异(P<0.01),继续增加给药剂量药效逐渐降低。
5.从甘麦大枣汤抗焦虑作用的时效关系研究可知:给药3天时与本组空白组比较,OE%具有显著性差异(P<0.05),给药7天OE%达到最大值与本组空白组比较具有极显著性差异(P<0.01),继续增加给药天数药效逐渐降低;给药5天时与本组空白组比较OT%具有显著性差异(P<0.05),给药7天OT%达到最大值与本组空白组比较具有极显著性差异(P<0.01),继续增加给药天数药效逐渐降低。
6.从甘麦大枣汤抗焦虑作用的作用机制研究可知:甘麦大枣汤能降低小鼠海马内5-HT的含量,与空白组比较具有极显著性差异(P<0.01)。
结论:
1.性别对高架十字迷宫实验结果的影响没有显著性统计学差异。
2.体重对高架十字迷宫实验结果有一定影响,体重为20.0g±1.0g的小鼠焦虑状态最明显。
3.测试时间对高架十字迷宫实验结果有一定影响,测试时间为14:00-17:00时小鼠焦虑状态最明显。
4.甘麦大枣汤抗焦虑作用呈现一定的量效关系和时效关系变化,但是不呈现剂量依赖性。最佳给药剂量为20倍剂量;最佳给药时长为连续给药7天。
5.甘麦大枣汤可能是通过降低小鼠脑内海马区5-HT的含量发挥抗焦虑作用。
Objective: Studies on the anxiolytic effect and function mechanism of Ganmaidazao Tang.
Methods: Take the mice as the object of study, application EPM duplication anxious animal model, from behavior study angle the anti-anxious function. From behavior study angle factors and so on observation sex, weighe, testing time to EPM experiment result influence; Based on this research about dose-response relationship and time-concentration of the Ganmaidazao tang anti-anxious; Used HPLC-EC technique, in determination the region of hippcampus mice 5-HT content change, determined Ganmaidazao Tang affects anxious function mechanism.
Results:
1. Sex to experimental result influence:female group and male group OE%,OT% and locomotor activity P>0.05.
2. Weight to experimental result influence: compares with the weight for 20.0±1.0g group, the weight for 15.0g±1.0g group OE% P<0.05, 25.0g±1.0g group OE%P<0.01;15.0g±1.0g and 25.0g±1.0g group OT%P<0.01; 15.0g±1.0g group locomotor activity P<0.05.
3. Test time to experimental result influence:compares with the 14:00-17:00 group, 19:00-21:00 group OE% P<0.05; 9:00-12:00 group OT% P<0.05, 19:00-21:00 group OT% P<0.01; 9:00-12:00 group locomotor activity P<0.01.
4. The experimental results of the dose-response relationship showed that from the doses of 7.0g/kg started work there was significant difference OE% P<0.01; the doses of 14.g/kg reached the climax, there was extremely significant difference between the OE% and OT%; the doses of 3.5g/kg OT% P<0.05.
5 . The experimental results of the time-response relationship showed: the experimental results of the time- concentration relationship showed that giving medicine for three days started work, OE% P<0.05; giving medicine for seven days reach the climax, there was extremely significant different between OE% and OT% P<0.01; giving medicine for five days OT% P<0.05.
6. The experimental results of function mechanism of Ganmaidazao Tang, it can reduce content 5-HT of the region of hippocampus mice P<0.01.
Conclusion:
1. The sex hasn’t affect EPM results.
2. The weight affects EPM results: weight of 19.0g-21.0g is better.
3. Test time affects EPM results: test time of 14:00-17:00 is better.
4. Ganmaidazao Tang could improve the OE% and OT%,14.0g/kg is choosed for the best doses, seven days is choosed for the best time.
5. Ganmaidazao Tang can reduce content 5-HT of the region of hippcampus mice
引文
[1]杨德森.神经衰弱研究现状.中华精神科学会神经症与应激相关疾病会议论文集.1999:27-30.
[2]郝俊卿.甘麦大枣汤治疗脏躁体会[J].山西中医学院学报.2008,9(6):36
[3]古金光等.养心益胆法治疗焦虑性神经官能症73例[J].山东中医杂志.2000, 19(7): 408-409
[4]朱晨军.中医药治疗焦虑症的研究进展[D].北京中医药大学硕士学位文.2007:5
[5]于俊丽,孙俊玲.安神定志汤配合西药治疗焦虑症100例[J].河南实用神经疾病杂志.1999,2(4):58一59
[6]陈加美,卢胜利.滋阴降火治疗焦虑症[J].美国中华心身医学杂志.1995 ,2(3):184
[7]王牛武.宁神定志汤治疗焦虑症48例[J].湖南中医药导报.1998, 4(5):26-27
[8]刘荔.刘启庭经方验案选[J].时珍国医国药.1999, 10(10):778-779
[9]王照程.逍遥散加减治疗神经官能症47例[J].福建中医药.1999, 30(5):26-27
[10]胡健琴,李虎元.中西医结合治疗青少年焦虑症50例[J].甘肃中医.1999, 12(5): 24
[11]孟昭蓉等.清心涤痰汤治疗痰火内扰型广泛性焦虑症40例[J].四川中医. 2001,19(1):27
[12]孙松涛.柴胡加龙骨牡蛎汤加减治疗广泛性焦虑症72例[J].中医杂志.2000,41(2):95
[13]迟延威.中西医结合治疗焦虑性神经症[J].黑龙江医学.2002,25(10):78
[14]王再涛.天王补心丹加减治疗焦虑症72例[J].实用医学杂志.2001,19(7):408-409
[15]郑小明.谈谈焦虑症的表现及其治疗[J].高等教育研究.2000,16(4):53-55
[16]张亚林.神经症理论与实践[M].北京:人民卫生出版社,2000:180-185
[17] Ghoneim M.M.and Mewaldt S.P.Benzodiazepines and humam memory:A review. Anesthesiology. 1990, 72:926-938
[18]冯辉.焦虑症的研究近况[J].吉林中医药.2003, 4(3):48一49
[19] Rdemond D.E.Neurochemical basis for anxiety and anxiety disorders:evidencefrom durgs which deereaxiety human fear for anxiety.In A.H. Tuma. &J.D. Maser (Eds.). Anxiety and the AnxietyDisorders. 1985,530-555
[20] Crowe RR,Noyes R,Pauls DL,et al.A family study of panic disorder.Arch Gen Psychiatry,1983,40(10):1065-1069
[21] Torgersen S.Genetic factors in anxiety disorders.Arch Gen Psychiatry, 1983, 40(10):1085-1089
[22] Crowe RR,Noyes R,Pauls DL,et al.A family study of panic disorder.Arch Gen Psychiatry,1983,40(10):1065-1069
[23] Torgersen S.Genetic factors in anxiety disorders.Arch Gen Psychiatry, 1983, 40(10):1085-1089
[24] Kendler KS,Neale MC,Kessler RC,et al.Generalized anxiety disorder in women.A populationbased twin study.Arch GenPsychiatry,1992,49(4):267-272
[25] Kendler KS,Silberg JL,Neale MC,et al.Genetic and environmental factors in the aetiology of menstrual,premenstrual and neurotic symptoms:a population based twin study.Psychol Med,1992,22(1):85-100
[26]杨权.恐惧和焦虑的神经生物学研究[J].中华精神科杂志.2000,33(3)191-192
[27] Papp LA,Goetz R,Cole R,et al.Hypersensitivity to carbon dioxide in panic disorder.Am J Psychiatry,1989,146(6):779-781
[28] Hollander E,Liebowitz MR,Cohen B,et al.Prolactin and sodium lactate induced panic.Psychiatry Res,1989,28(2):181-191
[29]林雄标,黄明生.惊恐障碍与广泛性焦虑障碍的临床对比及血乳酸胆碱酯酶测定[J].中华精神科杂志.1993,26(6):348-351
[30]沈渔邨.精神病学[M].第三版北京人民卫生出版社.1995,56-59
[31]张克让,谭秀桃,马惠霞.神经症患者超氧化物歧化酶谷胱甘肽超氧化物酶及脂质超氧化物含量的变化[J].中华精神科杂志.1997,30(2):100-102
[32]周纪东,喻晓蔚.GABA人受体的神经药理学研究进展[J].生命的化学.2002,22(2):160-162
[33] Costs E. and Guidotti A. Molecular mechanism in the receptor action of benzodiazepines. Rev.Pharmac. Toxic. 1979, 19: 531-545
[34] Biggio G. , Cocas A. , CordaM.G. , et al. GABA ergic and dopaminergictransmission in the rat cerebral cortex:effect of stress,anxiolytic and anxiofenic drugs,Phar,ac.Ther.1990,48:121-142
[35] Biggo.,Corda M.G.,Demontis G. et al . Rapid changes tn GABA binding induced by stress in different areas of the rat brain. Brain Res.1981,229:363-369
[36] Jakson H.C.,Nutt D.j Effects of benzodiazepines receptor inverse agonists on locomotor activity and exploration in mice. Eur.J.Pharmacol.1992,221:199-204
[37] Dorow R.,Horowskl R.,Paschelke G.,Amin M.,Braestrup C.Severe anxiety induced by FG7142,a b-carboline ligand for benzodiazepines receptors. Lancet 1983,2:98-99
[38] Gentil v., Tavares S., Gorenstein C., Bello C., Mathias L., Gronich G., Singer J.Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505;inverse agonism tolerance and rebound.Psychopharmacology. 1990,100:54-59
[39] Graffe F.G., Guimeras T.S., and De Andrade T.G.Role of 5-HT in stress,anxiety and cepression. Pharmacol.Biochem. Behav. 1996, 86:334-338
[40] Bell C.J., Coplan J.D., Serotonin and panic. Br.J. Psychiatry.1998,172:456-471.
[41] Grobe G., Coplan J.D., and Hollanaer E. The neuroanatomy of 5-HT dysregulation and panic disorder.J.Neuropsychiantry Clin. Neurosci 1997. 9: 198-207
[42] Cowy. D.,et al.Archives of general psychiatry. 1990,47:277-284
[43]袁勇贵.国外医学精神病学分册[M].2000, 27(3):143-148
[44] Redmond D.E. and Huang Y.Current cincept:Ⅱ.New evidence for a locus coeruleus-norepinephrene connection with anxiety. Life Sciences. 1979,25:2144-2162
[45] Charney D.S., Heninger G.R., and Breier A. Noradrenergic function and panic anxiety effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of general poychiatry. 1984,41:751-763
[46] Rainy J.M.,Pohl R.B.Williams M., et al. A comparison of lactate and isoproterenol anxiety states, Psychopathology. 1984,17(suppl.1):74-82
[47] Nutt D.,and Lawson C. Panic attacks:a neurochemical overview of models and mechanisms. The British journal of psychiatry.1992, 160:165-178
[48]张汉霆.中枢阿片神经系统对焦虑情绪的调控作用极其机制探讨[J].生理科学进展.1997,28:41-44.
[49]马胜民,汤宜朗,翁永振.精神分裂症的谷氨酸假说[J].国外医学精神病学分册.1998,2:68-71
[50]周玻,王雪琦.谷氨酸能和γ氨基丁酸能神经系统与情感障碍[J].中华神经科学杂志.2003,19(2):130一133
[51]朱晓彤,季建林.焦虑的神经递质及生理变化的研究进展[J].上海精神医学.2001,13:222-224
[52]张汉霆.发展中的抗焦虑剂[J].国外医学药学分册.1996, 23:2-631
[53] Jones M., and Mellersh V.A comparison of the ecercise respone in anxiety states and normal controls. Psychosom. Med. 1946,8:180-187
[54] Pitts F.M., and McClure J.N.Lactate metagolism in anxiety neurosis. N. Engl. J. Med.1967,277:1392-1336
[55] Carr D.B., and Sheehan D.V. Panic anxiety: a new biological model. J. Clin.Psychiatry. 1984,45:323-330
[56] Liebowitz M.P., Fyer A.J., Gorman J.M., et al. Lactate provocation of panic attacks; I.Clinical and behavioral findings. Arch. Gen. Psychiatry: 1984, 41: 764-770
[57] Gorman J.M., Roetz R.R., Dillon D., et al. Sodium D-lactate infusion in panic disorder patients. Neuropsychopharmacology. 1990.3:181-189
[58] Lingjaerde O. Lactate-induced panic attacks: possible involvement of serotonin reuptake stimulation. Acta. Psyehiatr. Scandinavian1985. 72: 206-208
[59] Kiss,J.P., et al. Trends in Neurosciences. 2001,24:211-215
[60] Vale, A.L., et al Journal of Psychopharmacology. 1998,12(3):268-272
[61] Connor K.M., Davidson J.R. Generalized anxiety disorder: neurobilological and pharmacotherapeutic perspectives. Bilo Psychiatry. 1998,44(12):1286-1294
[62] Kunovac J.L., Stahl S.M.Future directions in anxiolytic Pharmacotherapy. Psychiatr Clin North Am. 1995, 18(4):895-909
[63] Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 2003, 463: 235-272
[64] Heilif M. Mcleod S, Bnt M, M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT. Anxiolytic-like action of neuropeptide Y:mediation by ay. Receptors in amygdale; and dissociation from food intake effects. Nearopsychopharmacolo- gy. 1993 Jun, 8(4): 357-363
[65]谢健,吴爱勤.广泛性焦虑障碍的神经生化和内分泌研究进展[J].国外医学(精神病学分册).2002,29:168-170
[66] Terasa, A.P., et al., The Journal of clinical psyxhiatry. 1999.60(suppl 18):4-15.
[67]汪春运.丫氨基丁酸和精神药理[J].国外医学(精神病学分册).2002 ,29(4):233-235
[68] Paul S.M., and Purdy R.H Neuroactive steroids. FASEBJ. 1992,6:2311-2322.
[69] Wieland S., Lan N.C., Mirascdeghi S, et al.Anxiolytic axtivity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 1991, 565:263-268
[70] Hoisboer F. The rationale forcorticotropin-releasing hormone receptor (CRh-R) antagonists to treat depression and znxiety. J. Psychiatr. Res. 1999, 33:181-214
[71] Brown G.W., Harris T.O., Eales M.T., Social factors and co-morbidity of depression and anxiety disorder. Br.J. Psychiatry 1996,188(30):50-57
[72] Ghomeim,M.M., and Mewaldt, S.P., Benzodiazepines and human momory. A review. Anesthesioligy. 1990,72:926-938
[73] Thebot,M.H., Le Bihan, C., Soubrie, P., Benzodiazepines and human memory : A review Anesthesiology. 1990,72:936-938
[74]刘慧芬等.焦虑的生物学机制[J].中国药物滥用防治杂志.2000,6:8-10
[75] Miczde, K.A., Weerts, E.M. Vivian, J. A., and Barros, H.M. Aggression, anciety and vocalization in animals: GABAA and 5-HT anxiolytic. Psychopharmacology. 1995, 121:38-56
[76] Hartley L.R., Ungaren S., Davie I., et al . The effect of beta advenergic blocking drugs on speaker’s performance and memory. Br. J. Psychiatry. 1983, 142:512-517
[77] Andersch S, Rosenberg NK, KullingsjoH, et al. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder A Scandinavianmulticenter study. Acta Psychiatr Scand Suppl. 1991,365:18-27
[78] Sargant W., and Pally P. Treatment of anxiety states by antidepressant drugs. British medical bulletin.1962,1:6-9
[79] Gabbard G.O. Treatments of Psychiatric Disorders. 3rd Ed, Vol. 2. Washington: American Psychiatric Publishing. 2001, 1447-1482: 1587-1622
[80]吴恺,胡夏生,罗盛.氯西汀和曲唑酮的抗焦虑作用[J].中国神经免疫学和神经病学杂志.2000,7(2):111-115
[81]张中启,罗质璞.丁螺环酮:一种新型抗焦虑剂[J].中国药理学通报.1993,9(3):174 178
[82] File S E,Pellow S.The effect of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.Journal de Pharmacologie. 1985,86(3):729~735
[83] Handley SL, Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of‘fear’-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol.1984,327(1):1-5
[84] Pellow S, Chopin P, File SE, et al. Validation of open:close arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods, 1985,14(3):149-167
[85] Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology(Berl), 1987,92(2):180-185
[86] Hogg S.A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmcol Biochem Behav, 1996,54(1):21-30
[87] Grigor’ev N.R., Batalova T.A., Kirichenko E.F. Typological Features in the Behavior of Rats. Neuroscience and Behavioral Physiology, 2008,38(6):597
[88] Post R M, Leverich G S, Xing G, et al. Developmental vulnerabilities to the onset and course of bipolar disorder. Development and Psychopathology,. 2001,13(3):581~598
[89] Treit D. Animal models for the study of anti-anxiety agents: a re-view. Neurosci Biobehav Rev, 1985, 9 : 203~222
[90]黄继忠,王祖承.焦虑动物模型的实验方法和药理学评价[J].Shanghai Archives of Psychiatry. 2003, 15(2):106-108
[91]李冀.方剂学[M].中国中医药出版社,006: 236-237.
[92]谢强敏,黄丽月等.甘麦大枣汤的药理研究[J].中药药理与临床.1992,8(6):6-9
[93]宋霄宏.甘麦大枣汤升白细胞作用的实验研究[J].浙江中医学院学报. 1990, 14(5)∶27
[94]吕圭源.复方甘麦大枣汤的药理研究[J].浙江中医学院学报.1992,16(6):46
[95]石森林,何三民等.甘麦大枣汤的制备方法研究简释[J].中医药学刊. 2003,21(12):2063
[96]王欣,谢鸣.酸枣仁汤对高架十字迷宫模型大鼠单胺类递质的影响[J].中国实验方剂学杂志. 2005,11(6):47-49
[97]张学礼,金国琴等.加味甘麦大枣汤对抑郁症模型大鼠行为学及单胺类神经递质的影响[J].中药药理与临床.2003,19(3):5-6
[2]郝俊卿.甘麦大枣汤治疗脏躁体会[J].山西中医学院学报.2008,9(6):36
[3]古金光等.养心益胆法治疗焦虑性神经官能症73例[J].山东中医杂志.2000, 19(7): 408-409
[4]朱晨军.中医药治疗焦虑症的研究进展[D].北京中医药大学硕士学位文.2007:5
[5]于俊丽,孙俊玲.安神定志汤配合西药治疗焦虑症100例[J].河南实用神经疾病杂志.1999,2(4):58一59
[6]陈加美,卢胜利.滋阴降火治疗焦虑症[J].美国中华心身医学杂志.1995 ,2(3):184
[7]王牛武.宁神定志汤治疗焦虑症48例[J].湖南中医药导报.1998, 4(5):26-27
[8]刘荔.刘启庭经方验案选[J].时珍国医国药.1999, 10(10):778-779
[9]王照程.逍遥散加减治疗神经官能症47例[J].福建中医药.1999, 30(5):26-27
[10]胡健琴,李虎元.中西医结合治疗青少年焦虑症50例[J].甘肃中医.1999, 12(5): 24
[11]孟昭蓉等.清心涤痰汤治疗痰火内扰型广泛性焦虑症40例[J].四川中医. 2001,19(1):27
[12]孙松涛.柴胡加龙骨牡蛎汤加减治疗广泛性焦虑症72例[J].中医杂志.2000,41(2):95
[13]迟延威.中西医结合治疗焦虑性神经症[J].黑龙江医学.2002,25(10):78
[14]王再涛.天王补心丹加减治疗焦虑症72例[J].实用医学杂志.2001,19(7):408-409
[15]郑小明.谈谈焦虑症的表现及其治疗[J].高等教育研究.2000,16(4):53-55
[16]张亚林.神经症理论与实践[M].北京:人民卫生出版社,2000:180-185
[17] Ghoneim M.M.and Mewaldt S.P.Benzodiazepines and humam memory:A review. Anesthesiology. 1990, 72:926-938
[18]冯辉.焦虑症的研究近况[J].吉林中医药.2003, 4(3):48一49
[19] Rdemond D.E.Neurochemical basis for anxiety and anxiety disorders:evidencefrom durgs which deereaxiety human fear for anxiety.In A.H. Tuma. &J.D. Maser (Eds.). Anxiety and the AnxietyDisorders. 1985,530-555
[20] Crowe RR,Noyes R,Pauls DL,et al.A family study of panic disorder.Arch Gen Psychiatry,1983,40(10):1065-1069
[21] Torgersen S.Genetic factors in anxiety disorders.Arch Gen Psychiatry, 1983, 40(10):1085-1089
[22] Crowe RR,Noyes R,Pauls DL,et al.A family study of panic disorder.Arch Gen Psychiatry,1983,40(10):1065-1069
[23] Torgersen S.Genetic factors in anxiety disorders.Arch Gen Psychiatry, 1983, 40(10):1085-1089
[24] Kendler KS,Neale MC,Kessler RC,et al.Generalized anxiety disorder in women.A populationbased twin study.Arch GenPsychiatry,1992,49(4):267-272
[25] Kendler KS,Silberg JL,Neale MC,et al.Genetic and environmental factors in the aetiology of menstrual,premenstrual and neurotic symptoms:a population based twin study.Psychol Med,1992,22(1):85-100
[26]杨权.恐惧和焦虑的神经生物学研究[J].中华精神科杂志.2000,33(3)191-192
[27] Papp LA,Goetz R,Cole R,et al.Hypersensitivity to carbon dioxide in panic disorder.Am J Psychiatry,1989,146(6):779-781
[28] Hollander E,Liebowitz MR,Cohen B,et al.Prolactin and sodium lactate induced panic.Psychiatry Res,1989,28(2):181-191
[29]林雄标,黄明生.惊恐障碍与广泛性焦虑障碍的临床对比及血乳酸胆碱酯酶测定[J].中华精神科杂志.1993,26(6):348-351
[30]沈渔邨.精神病学[M].第三版北京人民卫生出版社.1995,56-59
[31]张克让,谭秀桃,马惠霞.神经症患者超氧化物歧化酶谷胱甘肽超氧化物酶及脂质超氧化物含量的变化[J].中华精神科杂志.1997,30(2):100-102
[32]周纪东,喻晓蔚.GABA人受体的神经药理学研究进展[J].生命的化学.2002,22(2):160-162
[33] Costs E. and Guidotti A. Molecular mechanism in the receptor action of benzodiazepines. Rev.Pharmac. Toxic. 1979, 19: 531-545
[34] Biggio G. , Cocas A. , CordaM.G. , et al. GABA ergic and dopaminergictransmission in the rat cerebral cortex:effect of stress,anxiolytic and anxiofenic drugs,Phar,ac.Ther.1990,48:121-142
[35] Biggo.,Corda M.G.,Demontis G. et al . Rapid changes tn GABA binding induced by stress in different areas of the rat brain. Brain Res.1981,229:363-369
[36] Jakson H.C.,Nutt D.j Effects of benzodiazepines receptor inverse agonists on locomotor activity and exploration in mice. Eur.J.Pharmacol.1992,221:199-204
[37] Dorow R.,Horowskl R.,Paschelke G.,Amin M.,Braestrup C.Severe anxiety induced by FG7142,a b-carboline ligand for benzodiazepines receptors. Lancet 1983,2:98-99
[38] Gentil v., Tavares S., Gorenstein C., Bello C., Mathias L., Gronich G., Singer J.Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505;inverse agonism tolerance and rebound.Psychopharmacology. 1990,100:54-59
[39] Graffe F.G., Guimeras T.S., and De Andrade T.G.Role of 5-HT in stress,anxiety and cepression. Pharmacol.Biochem. Behav. 1996, 86:334-338
[40] Bell C.J., Coplan J.D., Serotonin and panic. Br.J. Psychiatry.1998,172:456-471.
[41] Grobe G., Coplan J.D., and Hollanaer E. The neuroanatomy of 5-HT dysregulation and panic disorder.J.Neuropsychiantry Clin. Neurosci 1997. 9: 198-207
[42] Cowy. D.,et al.Archives of general psychiatry. 1990,47:277-284
[43]袁勇贵.国外医学精神病学分册[M].2000, 27(3):143-148
[44] Redmond D.E. and Huang Y.Current cincept:Ⅱ.New evidence for a locus coeruleus-norepinephrene connection with anxiety. Life Sciences. 1979,25:2144-2162
[45] Charney D.S., Heninger G.R., and Breier A. Noradrenergic function and panic anxiety effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of general poychiatry. 1984,41:751-763
[46] Rainy J.M.,Pohl R.B.Williams M., et al. A comparison of lactate and isoproterenol anxiety states, Psychopathology. 1984,17(suppl.1):74-82
[47] Nutt D.,and Lawson C. Panic attacks:a neurochemical overview of models and mechanisms. The British journal of psychiatry.1992, 160:165-178
[48]张汉霆.中枢阿片神经系统对焦虑情绪的调控作用极其机制探讨[J].生理科学进展.1997,28:41-44.
[49]马胜民,汤宜朗,翁永振.精神分裂症的谷氨酸假说[J].国外医学精神病学分册.1998,2:68-71
[50]周玻,王雪琦.谷氨酸能和γ氨基丁酸能神经系统与情感障碍[J].中华神经科学杂志.2003,19(2):130一133
[51]朱晓彤,季建林.焦虑的神经递质及生理变化的研究进展[J].上海精神医学.2001,13:222-224
[52]张汉霆.发展中的抗焦虑剂[J].国外医学药学分册.1996, 23:2-631
[53] Jones M., and Mellersh V.A comparison of the ecercise respone in anxiety states and normal controls. Psychosom. Med. 1946,8:180-187
[54] Pitts F.M., and McClure J.N.Lactate metagolism in anxiety neurosis. N. Engl. J. Med.1967,277:1392-1336
[55] Carr D.B., and Sheehan D.V. Panic anxiety: a new biological model. J. Clin.Psychiatry. 1984,45:323-330
[56] Liebowitz M.P., Fyer A.J., Gorman J.M., et al. Lactate provocation of panic attacks; I.Clinical and behavioral findings. Arch. Gen. Psychiatry: 1984, 41: 764-770
[57] Gorman J.M., Roetz R.R., Dillon D., et al. Sodium D-lactate infusion in panic disorder patients. Neuropsychopharmacology. 1990.3:181-189
[58] Lingjaerde O. Lactate-induced panic attacks: possible involvement of serotonin reuptake stimulation. Acta. Psyehiatr. Scandinavian1985. 72: 206-208
[59] Kiss,J.P., et al. Trends in Neurosciences. 2001,24:211-215
[60] Vale, A.L., et al Journal of Psychopharmacology. 1998,12(3):268-272
[61] Connor K.M., Davidson J.R. Generalized anxiety disorder: neurobilological and pharmacotherapeutic perspectives. Bilo Psychiatry. 1998,44(12):1286-1294
[62] Kunovac J.L., Stahl S.M.Future directions in anxiolytic Pharmacotherapy. Psychiatr Clin North Am. 1995, 18(4):895-909
[63] Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 2003, 463: 235-272
[64] Heilif M. Mcleod S, Bnt M, M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT. Anxiolytic-like action of neuropeptide Y:mediation by ay. Receptors in amygdale; and dissociation from food intake effects. Nearopsychopharmacolo- gy. 1993 Jun, 8(4): 357-363
[65]谢健,吴爱勤.广泛性焦虑障碍的神经生化和内分泌研究进展[J].国外医学(精神病学分册).2002,29:168-170
[66] Terasa, A.P., et al., The Journal of clinical psyxhiatry. 1999.60(suppl 18):4-15.
[67]汪春运.丫氨基丁酸和精神药理[J].国外医学(精神病学分册).2002 ,29(4):233-235
[68] Paul S.M., and Purdy R.H Neuroactive steroids. FASEBJ. 1992,6:2311-2322.
[69] Wieland S., Lan N.C., Mirascdeghi S, et al.Anxiolytic axtivity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 1991, 565:263-268
[70] Hoisboer F. The rationale forcorticotropin-releasing hormone receptor (CRh-R) antagonists to treat depression and znxiety. J. Psychiatr. Res. 1999, 33:181-214
[71] Brown G.W., Harris T.O., Eales M.T., Social factors and co-morbidity of depression and anxiety disorder. Br.J. Psychiatry 1996,188(30):50-57
[72] Ghomeim,M.M., and Mewaldt, S.P., Benzodiazepines and human momory. A review. Anesthesioligy. 1990,72:926-938
[73] Thebot,M.H., Le Bihan, C., Soubrie, P., Benzodiazepines and human memory : A review Anesthesiology. 1990,72:936-938
[74]刘慧芬等.焦虑的生物学机制[J].中国药物滥用防治杂志.2000,6:8-10
[75] Miczde, K.A., Weerts, E.M. Vivian, J. A., and Barros, H.M. Aggression, anciety and vocalization in animals: GABAA and 5-HT anxiolytic. Psychopharmacology. 1995, 121:38-56
[76] Hartley L.R., Ungaren S., Davie I., et al . The effect of beta advenergic blocking drugs on speaker’s performance and memory. Br. J. Psychiatry. 1983, 142:512-517
[77] Andersch S, Rosenberg NK, KullingsjoH, et al. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder A Scandinavianmulticenter study. Acta Psychiatr Scand Suppl. 1991,365:18-27
[78] Sargant W., and Pally P. Treatment of anxiety states by antidepressant drugs. British medical bulletin.1962,1:6-9
[79] Gabbard G.O. Treatments of Psychiatric Disorders. 3rd Ed, Vol. 2. Washington: American Psychiatric Publishing. 2001, 1447-1482: 1587-1622
[80]吴恺,胡夏生,罗盛.氯西汀和曲唑酮的抗焦虑作用[J].中国神经免疫学和神经病学杂志.2000,7(2):111-115
[81]张中启,罗质璞.丁螺环酮:一种新型抗焦虑剂[J].中国药理学通报.1993,9(3):174 178
[82] File S E,Pellow S.The effect of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.Journal de Pharmacologie. 1985,86(3):729~735
[83] Handley SL, Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of‘fear’-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol.1984,327(1):1-5
[84] Pellow S, Chopin P, File SE, et al. Validation of open:close arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods, 1985,14(3):149-167
[85] Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology(Berl), 1987,92(2):180-185
[86] Hogg S.A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmcol Biochem Behav, 1996,54(1):21-30
[87] Grigor’ev N.R., Batalova T.A., Kirichenko E.F. Typological Features in the Behavior of Rats. Neuroscience and Behavioral Physiology, 2008,38(6):597
[88] Post R M, Leverich G S, Xing G, et al. Developmental vulnerabilities to the onset and course of bipolar disorder. Development and Psychopathology,. 2001,13(3):581~598
[89] Treit D. Animal models for the study of anti-anxiety agents: a re-view. Neurosci Biobehav Rev, 1985, 9 : 203~222
[90]黄继忠,王祖承.焦虑动物模型的实验方法和药理学评价[J].Shanghai Archives of Psychiatry. 2003, 15(2):106-108
[91]李冀.方剂学[M].中国中医药出版社,006: 236-237.
[92]谢强敏,黄丽月等.甘麦大枣汤的药理研究[J].中药药理与临床.1992,8(6):6-9
[93]宋霄宏.甘麦大枣汤升白细胞作用的实验研究[J].浙江中医学院学报. 1990, 14(5)∶27
[94]吕圭源.复方甘麦大枣汤的药理研究[J].浙江中医学院学报.1992,16(6):46
[95]石森林,何三民等.甘麦大枣汤的制备方法研究简释[J].中医药学刊. 2003,21(12):2063
[96]王欣,谢鸣.酸枣仁汤对高架十字迷宫模型大鼠单胺类递质的影响[J].中国实验方剂学杂志. 2005,11(6):47-49
[97]张学礼,金国琴等.加味甘麦大枣汤对抑郁症模型大鼠行为学及单胺类神经递质的影响[J].中药药理与临床.2003,19(3):5-6